Get An Even Better Deal On CRMD Than Director Kaplan Did
July 26, 2021 at 11:15 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 17, CorMedix Inc's Director, Myron Kaplan, invested $90,477.00 into 15,000 shares of CRMD, for a cost per share of $6.03..